CCXI On Other Exchanges
Symbol
Exchange
CCXI is not on other exchanges.

Executive Profile*

Roger C. Lucas

Lead Independent Director,ChemoCentryx, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 3 different industries.

See Board Relationships
75--

Background*

Dr. Roger C. Lucas, Ph.D. co-founded Techne Corp., in 1985 and has been its Chief Scientific Advisor since 1995. Dr. Lucas is an Investor in ChemoCentryx and a Founding Member of the staff at R&D Systems, a division of Techne. He served as Senior Scientific Advisor of Techne Corp. since July 1995. He served as Chief Scientific Officer, Executive Vice President and Secretary of Techne Corp. from December 1985 to March 1995. He served as Vice President of Research at R&D ...

Read Full Background

\

Corporate Headquarters*

850 Maude Avenue
Mountain View, California 94043

United States

Phone: 650-210-2900
Fax: 650-210-2910

Board Members Memberships*

1997-Present
Lead Independent Director

Education*

PhD
Illinois Institute of Technology
BA
Saint Mary's College Of California

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gregory A. Demopulos Co-Founder, Chairman, CEO & President
Omeros Corporation
--
Hervé Hoppenot Chairman of the Board, President & CEO
Incyte Corporation
--
Nina Webster Ph.D., M.IP.Law, MBACEO, MD & Director
Dimerix Limited
--
Stephen J. Aselage CEO, President & Director
Retrophin, Inc.
--
Mark Christopher Trudeau President, CEO & Director
Mallinckrodt Public Limited Company
$1.0M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHEMOCENTRYX INC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.